Pyragrel Sodium
Tier C — Watch / tradePyragrel Sodium
Targets:TBXAS1
Indications (approved):Cerebral infarction, 运动障碍
Regional status
Synthetic routes & intermediates1 routes
Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.
| Code | CAS No. | Intermediate |
|---|---|---|
| TSF-001 | 537-98-4 | (E)-3-(4-hydroxy-3-methoxyphenyl)acrylic acid |
| TSF-002 | 28028-62-8 | ethyl (E)-3-(4-hydroxy-3-methoxyphenyl)acrylate |
| TSF-003 | 123624-90-8 | 2-(chloromethyl)-3,5,6-trimethylpyrazine |
| TSF-004 | 1018438-90-8 | ethyl (E)-3-(3-methoxy-4-((3,5,6-trimethylpyrazin-2-yl)methoxy)phenyl)acrylate |
| Pyragrel Sodium | 1613638-20-2 | sodium (E)-3-(3-methoxy-4-((3,5,6-trimethylpyrazin-2-yl)methoxy)phenyl)acrylate |
Frequently asked questions
What are the approved indications of Pyragrel Sodium?
Approved indications include: Cerebral infarction, 运动障碍.
When does the Pyragrel Sodium patent expire?
No public expiry year is available for Pyragrel Sodium yet; this page updates once verified.
How many synthesis routes are recorded for Pyragrel Sodium?
1 synthesis routes are recorded; the shortest is 3 steps with / total yield. Intermediates in each route carry codes and CAS numbers.
Where can I buy Pyragrel Sodium intermediates?
All intermediates in Pyragrel Sodium routes have CAS profiles — you can submit an RFQ per CAS and it enters the Unibest matching pool.
How do I get a quote for Pyragrel Sodium intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-22